Clinical mastitis: incidence, etiology and treatment in organic and converting dairy herds

Similar documents
The mastitis situation in Canada where do you stand?

EXISTING RESEARCH ABOUT THE ROLE OF VETERINARIANS ON ORGANIC DAIRIES

Outline MILK QUALITY AND MASTITIS TREATMENTS ON ORGANIC 2/6/12

Using SCC to Evaluate Subclinical Mastitis Cows

MALLA HOVI & STEVE RODERICK, Veterinary Epidemiology and Economics Unit, University of Reading, PO Box 236, READING RG6 6AT

MASTITIS CASE MANAGEMENT

Mastitis: Background, Management and Control

2012 Indiana Regional Dairy Meetings. Purdue University College of Veterinary Medicine Dr. Jon Townsend Dairy Production Medicine

Dairy/Milk Testing Report Detecting Elevated Levels of Bacteria in Milk-On-Site Direct- From-The-Cow Within Minutes as Indicator of Mastitis

Interpretation of Bulk Tank Milk Results

How to Decrease the Use of Antibiotics in Udder Health Management

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved

Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory

Management Practices and Intramammary Infections: New Ideas for an Old Problem

Walter M. Guterbock, DVM, MS Veterinary Medicine Teaching and Research Center University of California, Davis

MILK COMPOSITIONAL CHANGES DURING MASTITIS

, Pamela L. Ruegg

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

Controlling Contagious Mastitis

Mastitis MANAGING SOMATIC CELLS COUNTS IN. Somatic Cell Count Are Affected by. Somatic Cells are NOT Affected by:

Emerging Mastitis Threats on the Dairy Pamela Ruegg, DVM, MPVM Dept. of Dairy Science

MASTITIS DNA SCREENING

Milk Quality Management Protocol: Fresh Cows

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Premiums, Production and Pails of Discarded Milk How Much Money Does Mastitis Cost You? Pamela Ruegg, DVM, MPVM University of Wisconsin, Madison

Using DHIA and bacteriology to investigate herd milk quality problems.

Validation of the PathoProof TM Mastitis PCR Assay for Bacterial Identification from Milk Recording Samples

Interpretation and Use of Laboratory Culture Results and the Characteristics of Various Mastitis Pathogens

Pathogen Identification And Incidence Rates Of Clinical Mastitis On Organic And Conventional Dairy Farms

TEAT DIP- POST DIP- PRE DIP- STRIPING

Minna Koivula & Esa Mäntysaari, MTT Agrifood Research Finland, Animal Production Research, Jokioinen, Finland

Strep. ag.-infected Dairy Cows

On- farm milk culture training workshop

Risk factors for clinical mastitis, ketosis, and pneumonia in dairy cattle on organic and small conventional farms in the United States

Interpretation of results from milk samples tested for mastitis bacteria with Mastit 4 qpcr test from DNA Diagnostic

MASTITIS. Therefore, mastitis is an inflammation of the mammary gland.

On-farm milk culture training workshop. Christina Petersson-Wolfe Department of Dairy Science Virginia Tech

Practical Strategies for Treating Mastitis Pamela L. Ruegg, DVM, MPVM University of Wisconsin, Madison

RISKS, REALITIES AND RESPONSIBILITIES ASSOCIATED WITH MASTITIS TREATMENTS

Milk Quality Evaluation Tools for Dairy Farmers

LOOKING FOR PROFITS IN MILK QUALITY

Decision tree analysis of treatment strategies for mild and moderate cases of clinical mastitis occurring in early lactation

Northern NY Agricultural Development Program 2016 Project Report

Milk quality & mastitis - troubleshooting, control program

De Tolakker Organic dairy farm at the Faculty of Veterinary Medicine in Utrecht, The Netherlands

BIOSECURITY ON DAIRIES... ARE WE DOING ENOUGH?

Quad Plate User s Manual

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

Quality Milk on Pasture Based Dairy Farms. Scott E. Poock, DVM University of Missouri Clinical Assistant Professor DABVP Beef and Dairy Cattle

April Boll Iowa State University. Leo L. Timms Iowa State University. Recommended Citation

The Condition and treatment. 1. Introduction

Evaluation of a new qpcr test to specify reasons behind total bacterial count in bulk tank milk

Comparison of different methods to validate a dataset with producer-recorded health events

Mastitis: The Canadian Perspective

Sources of Different Mastitis Organisms and Their Control

GHI-Thailand Dairy farming in Chiang Mai, Thailand. Khwanchai Kreausukon Faculty of Veterinary Medicine Chiang Mai University

Selective Antibiotic Treatment for Dairy Cow Mastitis 1

Herd Navigator and mastitis management

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

Trouble-Shooting a Mastitis Problem Herd 1

Innovation in Mastitis Treatment

Association between teat skin colonization and intramammary infections with Staphylococcus aureus and Streptococcus agalactiae

DAIRY VETERINARY NEWSLETTER

Update on Staphylococcus aureus Mastitis. John R. Middleton College of Veterinary Medicine, University of Missouri, Columbia

A PRACTISING VETS APPROACH TO THE HIGH CELL COUNT HERD

Summary. Table 1. Estimated infection prevalence and losses in milk production associated with elevated bulk tank somatic cell counts.

TREATMENT DECISIONS FOR MILD AND MODERATE CASES OF CLINICAL MASTITIS. Carolina Pinzón-Sánchez

Effect of omitting post-milking teat disinfection on the mastitis infection rate of dairy cows over a full lactation

PREVALENCE OF SUBCLINICAL MASTITIS AND ANTIBIOTIC RESISTANT BACTERIA IN THREE SELECTED CATTLE, FARMS IN SERDANG, SELANGORAND KLUANG, JOHOR

IDENTIFICATION OF MASTITIS ETIOLOGIC AGENTS IN LITHUANIAN CATTLE HERDS

29/11/2017. Best Milking Practices. Greg Strait- Fulton County Extension Amber Yutzy- Huntingdon County Extension

The use of on-farm culture systems for making treatment decisions

Evaluation of intervention strategies for subclinical and clinical mastitis

Lactation. Macroscopic Anatomy of the Mammary Gland. Anatomy AS 1124

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

Options for Handling Mastitis during Lactation in Modern Dairy Farms

Prevalence of sub clinical mastitis in small holder dairy farms in Selale, North Shewa Zone, Central Ethiopia

Advanced Interherd Course

Mastitis in ewes: towards development of a prevention and treatment plan

Veterinaria.com.pt 2009; Vol. 1 Nº 1: e13 (publicação inicial em Julho de 2008) Disponível em

1 st EMP-meeting: European boom in AMS and new tools in mastitis prevention

Mastitis Module Risk Assessment Guide by Pathogen. Streptococcus agalactiae

MILK QUALITY PROGRAMS FOR TRANSITION COWS AND HEIFERS. Leo Timms Iowa State University, Ames IA

DeLaval Cell Counter ICC User Strategies Guide

Field Efficacy of J-VAC Vaccines in the Prevention of Clinical Coliform Mastitis in Dairy Cattle

Ren Tip # 84 11/6/15

Bulk Milk Data and Udder Health

Influence of Management Techniques on the Levels of Mastitis in an Organic Dairy Herd Mastitis management in organic herd

MASTITIS PATHOGENS IN MILK OF DAIRY COWS IN SLOVAKIA

& chicken. Antibiotic Resistance

Bovine Mastitis: Prevalence and Antibiotic Resistance of Staphylococcus Aureus in Small Holder Herds of Bench Maji Zone, Southern Ethiopia

Development and Daily Management of an Explicit Strategy of Nonuse of Antimicrobial Drugs in Twelve Danish Organic Dairy Herds

Policies of UK Supermarkets: Liquid milk

Genetic and Genomic Evaluation of Mastitis Resistance in Canada

Health traits and their role for sustainability improvement of dairy production

Herd Health Plan. Contact Information. Date Created: Date(s) Reviewed/Updated: Initials: Date: Initials: Date: Farm Manager: Veterinarian of Record:

Prudent use of antimicrobial agents Dairy Sector Initiatives. Robin Condron Dairy Australia

CLINICAL MASTITIS PERCEPTIONS OF KANSAS DAIRY PRODUCERS. J.R. Roberson 1

Prototheca Mastitis in Dairy Cows

Transcription:

Clinical mastitis: incidence, etiology and treatment in organic and converting dairy herds Research Traineeship Faculty of Veterinary Medicine University of Utrecht January 20th 2009, Calgary Student: Drs. G.J. van Embden 0362980 Supervisors: Dr. H.W. Barkema Faculty of Veterinary Medicine University of Calgary, Canada Dr. R. Jorritsma Faculty of Veterinary Medicine University of Utrecht, The Netherlands 1

CONTENTS CONTENTS 2 ABSTRACT 3 INTRODUCTION 3 ORGANIC DAIRY FARMING 4 Organic airy farming in Canada CLINICAL MASTITIS IN ORGANIC AND CONVERTING DAIRY HERDS 5 Incidence Etiology Antimocrobial drug usage and susceptibility related to clinical mastitis treatment ALBERTA ORGANIC DAIRY RESEARCH PROJECT 8 MATERIALS AND METHODS 9 Herds Sampling Laboratory analysis Descriptive statistics RESULTS 10 Incidence Etiology Treatments DISCUSSION 12 Results Significance CONCLUSIONS 13 ACKNOWLEDGEMENTS 14 REFERENCES 14 2

ABSTRACT Organic food production is a growing sector worldwide and anticipates to the consumer growing demand for food produced on a sustainable way, without the use of antibiotics, chemicals and pesticides, and better animal health and welfare. This report compares health and welfare between organic and conventional dairy farms by a literature review and a field study done in Alberta, Canada, with emphasis on clinical mastitis incidence, etiology and antibiotic usage. Animal welfare in organic farming is on average better than in conventional dairy farming, but health is not necessarily better. Organic regulations and management standards cannot guarantee better health because they do not influence management style. In most studies on health and welfare in organic dairy farming, mastitis is used as a parameter to measure animal health. In these studies, incidence of clinical mastitis varied from a lower incidence to a same or even higher incidence rate on organic farms compared to conventional. In several studies, distribution of mastitis pathogens cultured from cases of clinical mastitis showed a slight tendency towards more contagious pathogens in organic farms compared to conventional farms. Antibiotic resistance is expected to be lower on organic farms, but no general higher susceptibility of mastitis pathogens to antimicrobial drugs was proven in any of the studies, except in the USA, where difference in antibiotic usage between organic and conventional dairy farms is very high. In the field study, which was performed within the Alberta Organic Dairy Research Project, all clinical mastitis cases in organic farms were sampled and cultured over a period of 2 months. Results were then compared with data of conventional farms obtained from a national cohort study about udder health, performed by the Canadian Bovine Mastitis Research Network (CBMRN). Unfortunately, no associations with production method (organic vs. conventional) could be made for incidence and etiology of clinical mastitis and antibiotic resistance at this time, because of the low number of samples collected so far. Abbreviation key: CNS = coagulase-negative staphylococci, CON = conventional, IRCM = incidence rate of clinical mastitis, ORG = organic INTRODUCTION Organic production is defined by the International Federation for Organic Agriculture Movement (IFOAM) as a production system that sustains the health of soil, ecosystems and people [ ] (IFOAM, 2007). This definition is based on the 4 principles of organic (ORG) production: health, common sense, ecology and care (IFOAM principles). Consumers of today expect more and more of the quality of food of animal origin. Not only are the primary quality requirements as taste, color, and smell and food safety very important. Secondary quality requirements like animal health and welfare, striving for an ecological sustainable way of production, and the absence of chemicals, pesticides and antibiotics and fair market prices have become increasingly important. Organic agriculture is anticipating to these new and growing consumers demands. In spite of that, the current organic market was still less than 1% of the total world food market in 2005, although it is a strong growing sector worldwide (Bonny, 2006; Willer et al., 2006). 3

ORGANIC DAIRY FARMING Organic dairy farming in Canada The organic food sector in Canada is growing fast as well, among which the organic dairy industry (Macey, 2004; Agriculture and Agri-Food Canada, 2007). Most of the organic milk is produced by farms in the provinces British Columbia, Quebec and Ontario. Because of the great demand for organic milk the number of organic dairy farmers is increasing, partly because conventional (CON) dairy farms convert to ORG. In Ontario for example, the number of ORG dairy farms increased by 162% from 2001 till 2007 (Agriculture and Agri-Food Canada, 2007). To become ORG as a CON dairy farm and to comply with the ORG standards of IFOAM, the farm has to be certified after a period of transition by a certification body which relates to IFOAM. The exact rules to be followed when converting to ORG and maintaining ORG status in Canada are described in the Organic production systems general principles and management standards of the National Board of Standards of Canada and are comparable to regulations used in European countries. The transition period for dairy consists of a one year period in which the management will be adjusted step by step to the demands of ORG production certification. Nutrition, housing, breeding policy, use of pasture, raising of young stock and disease control all have to be adjusted. If a dairy farm produces its own feeding crops, land and crops have to be ORG as well. Fertilizer and pesticides cannot be used for a transition period of 3 years before any crop or pasture is ORG and must be fed to ORG dairy cows according the standards. After the one year period of transition the produced milk can be sold as ORG milk for premium prices (Organic production systems General principles and management standards, 2006). Antibiotics should not be used at drying off and are only allowed therapeutically during lactation in case of emergency, if a cow is very sick and animal welfare is compromised. When used in emergency cases, a veterinarian must be consulted for diagnosing the cause of disease and prescribing or administering antibiotic treatment, and withdrawal times are twice as long as labelled with a minimum of 14 days. If a dairy cow is treated more than twice per lactation with antibiotics or antiparasitics, the meat and milk can be sold as ORG only after another transition period of one year (Organic production systems General principles and management standards, 2006). These measures could compromise the control and treatment of clinical disease and the herd health and welfare in general, not only because of the restricted usage of antibiotics and antiparasitics, but also because the long withdrawal times which make treating animals economically inefficient. Accordingly, Sundrum (2001) stated in a critical review that health and product quality are not necessarily better in ORG dairy farms compared to CON dairy farms, and are more associated with management style than with production method. Organic livestock production is therefore no guarantee for good animal health; ORG standards seem to be not sufficient to assure a higher health status and a higher product quality and a considerable number of ORG dairy farms cannot cope with the high consumers demand by themselves. Animal husbandry is in competition with other fields of ORG agriculture and often fails to get priority. Also, measures that promote animal health and welfare are, to a certain degree, in contrast with the objectives of high production and low costs (Von Borell and Sorensen, 2004; Sundrum, 2001). Animal health and welfare in ORG dairy herds are therefore comparable or sometimes even lower compared to CON dairy herds. 4

CLINICAL MASTITIS IN ORGANIC AND CONVERTING DAIRY HERDS Incidence Mastitis is one of the main health issues in dairy production. The losses are not only economic, but also issues such as animal health and welfare, milk quality, antibiotic usage and the image of the dairy sector are important reasons to focus on mastitis control. Accordingly, mastitis is a topic that is well-studied worldwide (Lam, 2008). However, mastitis in ORG dairy farming is not studied well yet. Most studies that look into mastitis in ORG dairy herds are studies that look into general health and welfare in ORG dairy herds compared to CON dairy herds and use clinical mastitis incidence as a parameter to measure health and welfare. These studies had various outcomes. Some found lower incidence of clinical mastitis or lower numbers of clinical mastitis treatments in ORG dairy herds (Bennedsgaard et al., 2003; Hamilton et al., 2006; Hardeng and Edge, 2001), others found no significant difference between the two production systems (Fall et al., 2008; Sato et al., 2005; Valle et al., 2007; Weller and Bowling, 2000). In two studies there was no difference found in incidence of clinical mastitis, but ORG farms seem to have higher a bulk tank somatic cell count (Busato et al., 2000; Nauta et al., 2006). Hovi and Roderick (1998) did not found any difference in incidence of clinical mastitis between ORG and CON dairy farms as well, but showed that some ORG farms had relatively more cases of mastitis in the dry period compared to CON farms or other ORG farms. All these studies were comparisons between farms which all have their own general management. Circumstances varied therefore between farms and could possibly influence the outcomes and analysis of results. Fall et al. (2008) therefore performed a longitudinal comparative study on the differences in udder health between ORG and CON farms in which most variables in management were ruled out. Because in this study one research farm with both ORG as CON livestock was used, management style of the two groups was identical except for feeding and feed composition. Organic cows were fed according ORG standards, had all-year excess to pasture and twice the prescribed withdrawal time for milk when treated with antibiotics. All results were corrected for factors as lactation number, breed, season, year and milk yield. The study found no difference in clinical mastitis incidence between the two groups which were identical managed except for the pure ORG regulations applied to one of the groups. This confirms that management style has more influence on udder health than either the ORG or CON production method, as stated earlier by Sundrum (2001). Etiology Straw is often used as bedding in ORG farming and cows have excess to pasture in summer, while in CON farms cows are often kept indoors year round. Because of a difference in environmental factors between ORG and CON farms, a different distribution pattern of mastitis pathogens can be expected. Mastitis pathogens are divided into contagious, teat skin opportunistic and environmental mastitis pathogens, based on their pathophysiology and epidemiology. To make a further deviation, these three classes are all divided in major, minor and uncommon mastitis pathogens, based on their incidence and pathogenicity (Radostits et al., 2007). The major and minor udder pathogens are listed below in Table 1. For reasons of relevance, uncommon mastitis pathogens including bacteria, yeasts, leptospira and fungi are not included. In a study performed by Poll and Ruegg in Wisconsin, USA (2007), the proportion of several species (Streptococcus agalactiae, Strep. spp., coliforms and other species including Bacillus spp. and Corynebacterium bovis) of mastitis pathogens, isolated from cows with clinical mastitis, significantly differed between ORG and CON dairy farms and proportions were correlated with herd type. The proportions of isolates with Streptococcus spp. and 5

Escherichia coli were significant higher on CON farms, proportions of isolates with coagulase-negative staphylococci (CNS), S. agalactiae and other species were significantly higher on ORG farms. A higher percentage of samples obtained from CON farms had no growth compared to ORG and the incidence of all major and minor pathogens was higher on ORG farms, except for E. coli, which incidence was higher on CON farms. In conclusion, relatively more cases of clinical mastitis on CON farms were caused by environmental pathogens compared to ORG farms, while on ORG farms relatively more cases were caused by contagious pathogens compared to CON farms. TABLE 1. Major and minor pathogens causing bovine mastitis Contagious Teat skin opportunistic Environmental Major Streptococcus agalactiae Staphylococcus aureus Mycoplasma bovis Streptococcus uberis Streptococcus dysgalactiae Escherichia coli Klebsiella spp. Minor Corynebacterium bovis Coagulase-negative staphylococci (CNS) Coagulase-negative staphylococci (CNS) Streptococcus equinus Arcanobacterium pyogenes Enterobacter spp. Vaarst et al. (1997) studied patterns of clinical mastitis in ORG farms. They found that culture-negative samples were relatively often obtained from cows that had clinical signs very similar to acute clinical E. coli mastitis. In a study on Swiss ORG farms, Busato et al. (2000) reported a considerable increase in the incidence of new intramammary infections caused by Corynebacterium bovis between early to late lactation, while the proportion of S. aureus infections decreased. Some authors of earlier research suggested that quarters infected with C. bovis might be more resistant to subsequent infections with other pathogens (Busato et al., 2000; Radostits, 2007; Vaarst et al., 1997). The study further revealed that a remarkably high proportion of clinical mastitis cases was caused by contagious pathogens (82% in early lactation, 87% in late lactation). Busato et al. (2000) therefore concludes that a major problem in Swiss ORG farms is the transmission of contagious udder pathogens. Vaarst et al. (1997) also concludes that cow-related (contagious) bacteria are clearly the predominantly pathogens, as a study of Poll and Ruegg (2007) shows as well. However, the proportional distribution of the different pathogens individually varies widely between studies. Antimicrobial drug usage and susceptibility related to clinical mastitis treatment In ORG farming the use of chemicals is restricted to improve animal welfare and food quality. Because of that, the use of antibiotics is very limited by the ORG regulations (Canadian General Standards Board, 2006). However, within these regulations there are still possibilities to use antibiotics, as long as there is a veterinary indication and withdrawal times for ORG farming are followed. Hence, the usage of antibiotics is not only different compared to CON farms but also differs between ORG farms. Some ORG farmers are very strict in keeping the use of antibiotics as minimal as possible and put a lot of effort in treating cows alternatively, others are easier in using antibiotics and accept the long withdrawal times and loss of ORG status of cows, depending on their view on ORG farming and their farming objectives. In a study done by Vaarst et al. (2006), 12 Danish ORG farmers were interviewed who had an explicit goal for their herd to minimize the use of antibiotics to a very low level or no use at all. Instead of using antibiotics to cure disease, they tried to prevent disease by improving 6

living conditions, hygiene, milking routines and outdoor access and use alternative strategies to handle disease. The ORG dairy farmers gradually started to use California Mastitis Test (CMT) and bacteriological culturing on cows at risk of obtaining mastitis (e.g. fresh cows) and changed their response to disease from immediate treatment to intense follow-up. Alternative strategies used to lower the use of antibiotics in case of clinical mastitis were blinding chronic mastitis quarters, letting strong calves suckle at cows with clinical mastitis or treating with alternative medication such as peppermint ointment. All farmers, however, desired to preserve the possibility to use antibiotics in emergency cases because they all considered antimicrobial treatment as the treatment with best prognosis in case of severe illness. In another study, Vaarst et al. (2003) also found that ORG dairy farmers regarded antimicrobial treatment as the most responsible treatment, based on animal welfare considerations, with the best prognosis for cure. In the UK, Hovi and Roderick (1998) concluded in a study comparing mastitis treatment between ORG and CON farms, that homeopathy was the most frequently used alternative therapy to antibiotics for clinical mastitis treatment. Antibiotics were still used at ORG farms but in fewer cases. Conventional dairy farms used antibiotics in all clinical mastitis cases, whilst the ORG farms used antibiotics in only 41% of the cases and moreover, 56% of that was used by just one of the 15 participating ORG farms. Homeopathy was used in 52% of the cases and in 7% of the cases other alternatives, mostly topical udder ointments, were used. In the USA, where no use of antibiotics is tolerated in ORG farming without removing the treated animal from the ORG food chain (USDA, 2008), Zwald et al. (2004) performed a study to the use of antibiotics in ORG farms in the North West of the US. Herd type was significantly associated with percentage of the herd receiving antibiotic treatment, ORG farms using less than CON dairy farms. Only 50% of the ORG farms used antibiotics and from those farms, 14 out of 15 (93%) separated the treated animals from the ORG herd and sold the animal or kept it on a place where no physical contact with the ORG herd was possible. Separation was permanent on 13 of 14 farms and none of the previously treated animals on any of the ORG farms was sold for meat production. Because the usage of antimicrobial drugs is limited by regulation and proven to be lower in ORG dairy farming, it can be expected that major pathogens causing bovine clinical mastitis will get less in contact with antibiotics and consequently have a lower risk to become resistant to antibiotics (Roesch et al., 2006). Correlations between farm type (ORG vs. CON) and antimicrobial susceptibility for separate mastitis pathogens have been found in dairy farms in Wisconsin, USA (Poll and Ruegg, 2007). Staphylococcus aureus and Streptococcus spp. isolates obtained from cases of clinical mastitis on CON herds were more often resistant to pirlimycin and sulphonamides and to pirlimycin and tetracycline respectively compared to isolates obtained from ORG herds. Farm type was not associated with the MIC of other drugs tested with S. aureus, but S. aureus was more likely to be resistant to ampicillin and penicillin on CON farms compared to ORG farms. On both farm types only approximately 50% of the isolated S. aureus were inhibited by the lowest concentration of ceftiofur. Farm type was also correlated with antimicrobial susceptibility of CNS. CNS isolates obtained from CON herds were more resistant to ampicillin, penicillin, pirlimycin and tetracycline compared to isolates obtained from ORG farms (Poll and Ruegg, 2007). Poll and Ruegg (2007), however, only found a significant correlation between farm type and antimicrobial susceptibility in general (i.e. across different strains of mastitis pathogens) for pirlimycin. On ORG farms almost all isolated S. aureus were inhibited by pirlimycin compared to 75% on CON farms. A similar result was seen for Streptococcus spp. and coagulase-negative staphylococci (CNS); on ORG farms almost all Strep. spp. and CNS 7

isolates were susceptible for the lowest concentration of pirlimycin while only 64% of the Strep. spp. and 67% of the CNS isolates on CON farms were inhibited. In a study performed in Switzerland, Roesch et al. (2007) concluded that there was no significant difference in resistance of mastitis pathogens isolated from ORG and CON farms. Against what was expected, some of the mastitis pathogens isolated from ORG farms were even more resistant to some kinds of antimicrobial drugs than the same kind of pathogen isolated from CON dairy farms. This was the case in the resistance of S. aureus to tetracycline, ceftiofur, clindamycin, erythromycin, oxacillin and quinupristin-dalfopristin, which was only found in isolates obtained from ORG dairy farms. Also resistance of CNS to tetracycline, gentamicin, chloramphenicol and quinupristin-dalfopristin was found only on ORG farms, while resistance of CNS to erythromycin was only seen in isolates from CON farms. Resistance of Streptococcus uberis to clindamycin, erythromycin and quinupristindalfopristin was also found only in isolates obtained from ORG farms. Busato et al. (2000) concluded that no significant difference in resistance patterns of mastitis pathogens between ORG and CON dairy farms could be detected as well, and stated that in ORG dairy farming the same tendency of resistance of mastitis pathogens as in CON dairy farming can be seen. Moreover, Roesch et al. (2007) stated that resistance of mastitis pathogens in general is not influenced by the usage of antimicrobial treatment of mastitis or dry cow therapy and resistance to some antibiotics is even declining in some areas. It seems that only on ORG farms where antibiotic usage is zero or very limited, like in the USA, a lower level of resistance to antimicrobial drugs is seen in mastitis pathogens when comparing to CON farms. This could be explained by the fact that the average use of antibiotics in US CON dairy farms is very high while none is used in ORG dairy farms. In Scandinavian countries, where most studies on ORG farming are done, antibiotic usage is also very low in CON farms, so there is not much difference in antibiotic usage between ORG and CON. Consequently, lower levels of resistance in ORG relatively to CON farms are more likely to occur in countries where difference in antibiotic usage between ORG and CON is large. ALBERTA ORGANIC DAIRY RESEARCH PROJECT Because there has still little research been done on ORG dairy farming, the effect of transition period on production, herd management, health and welfare is not known well yet. Farmers who decide to transition from CON to ORG farming do not know well what to expect, e.g. what the quantity and quality of their milk production will be or how to handle health problems in an ORG way. This counts especially for Alberta farmers because they are among the first to become ORG in their region and therefore have no experienced peer group to compare with or learn from. To stimulate and facilitate future dairy farmers in Alberta to become ORG and know what to expect, more research has to be done about the effects of ORG farming. At the same time, industry partners, government agencies and researchers will benefit from the results. For these reasons the Alberta Organic Dairy Research Project has been set up, performing research on the first converting dairy farms of Alberta during a 3-year period. It serves as a pilot study preceding a greater national study, which will be handed in for funding to Dairy Farmers of Canada in April 2009. This report compares clinical mastitis incidence, etiology and treatment between dairy herds converting to ORG and CON dairy herds, by studying ORG farms in the Organic Dairy Project and compare them with results of the Canadian Bovine Mastitis Research Network. 8

MATERIALS AND METHODS Herds For the Organic Dairy Research Project, seven dairy farms in Alberta converting to ORG agreed to cooperate in the research. So far, only five farms are actively participating because the other two farms still have to start milking and do not have cows yet. All general information about the farms as stated below, is obtained by a short interview, the Dairy Herd Improvement (DHI) record keeping system and, to get a general impression, a walk around the farm on the first visit. The five farms all started or will start their one year period of ORG transition roughly around the same time, the earliest one at June 2008, the latest one at January 2009. The farms are scattered through the province from north to south, the most northern farm situated north-west of Edmonton, and the most southern farm situated just north of Calgary. The average herd size is 97 cows, ranging from 28 cows to 200 cows. The breeds used on these farms are mostly Holstein Friesian, Jersey and some crossbreds between Holstein Friesian and Jersey or Swiss Brown. At all farms artificial insemination is being used, while on one farm a bull is also used to breed the heifers. On all farms young stock is raised on the farm itself, no cows are bought on any farm. Cows have access to pasture in summer and exercise pens in winter. A comparison was made with results of CON farms obtained in a national cohort study, the Canadian Bovine Mastitis Research Network (CBMRN). In this project udder health on CON dairy farms throughout Canada is studied. To be able to compare results of the Organic Dairy Research Project with results of the CBMRN, only farms participating in the CBMRN located in the same region are used. In Alberta, 17 farms originally participated in this national project. Results used from this study are the outcomes of bacteriological cultured milk samples, obtained from cows with clinical mastitis from the 17 farms of Alberta over a period of 18 months. During the study, 4 farms could not complete the period of data collection, 2 of them because they stopped farming activities, one because the buildings were destroyed by fire, and one farm was asked to stop because of insufficient quality of data collection. Sampling At the first visit to the farms, farmers were explained what the part of health and welfare status of the project was about. Every farmer was handed out a binder in which records about diseases, culling and fertility and reproduction should be kept. For cases of clinical mastitis, sterile vials with labels, gausses and a 70%-alcohol solution were handed out so farmers could aseptically sample any quarter with clinical mastitis before they would administer any treatment of choice. Milk sample collection technique was discussed at the time of visit and described stepwise in the binder. Whenever a sample was taken, the quarter, clinical mastitis score, cow identification and sample date was written down by the farmer on the vial and on the mastitis form included in the binder. The clinical mastitis score is the severity of mastitis measured on a scale of 1 to 3. At grade 1, the quarter is normal but the milk abnormal (clots), at grade 2 abnormalities are observed in milk and udder (heat, redness, and/or swelling) and at grade 3, milk and udder are abnormal and systemic signs can be observed (depression, pyrexia). After collection, the sample was immediately stored in a freezer at -18 C. For treatment registration, garbage bins were handed out in which every used treatment was disposed. Treatment, cow ID, date, duration and reason of treatment have to be registered in the binder as well. The farms were visited every 2 months to pick up milk samples obtained from cows with clinical mastitis, collect treatments used in the last 2 months, checking and copying records from the binder and maintain a good relation with the farmers. Collected milk samples were then transported to the laboratory at the University of Calgary for bacteriological culture. 9

The culture results used from the CBMRN were obtained in a similar way. Milk samples were collected by the farmer and stored in a freezer, collected by a research technician every month and then bacteriologically cultured. All data belonging to the samples such as sample date, quarter, cow-id etc. was documented. General data of the farms, such as herd size, was also available. Laboratory analysis Milk from every sample was streaked on Agar plates and incubated at 37 C for 24h-48h. After overnight growth of culture-positive samples, morphology and hemolytic patterns of the colonies were determined and documented and organisms were differentiated by means of standard microbiologic procedures (National Mastitis Council, 1999). Culture results were then documented. Descriptive statistics The absolute incidence of clinical mastitis per farm was measured by counting all mastitis samples collected in both studies. Samples taken from the same cow or quarter with an interval of 14 days was regarded as two separate cow-cases of clinical mastitis (Barkema et al., 1998). Incidence rate of clinical mastitis (IRCM) was expressed as number of cow cases per 365 cow-days at risk. The relative incidence of the different mastitis pathogens was calculated as percentage of all quarter cases with the same pathogen on one type of farm, by dividing the number of cases of clinical mastitis caused by one specific pathogen by the total number of cases. Some quarter cases of mastitis were caused by two different pathogens, which were then counted separately. For each treatment of clinical mastitis on the ORG farms the used treatments per case were counted. RESULTS Incidence Because the Health and welfare status part of the Organic Dairy Research Project just started, only one sample collection round has been done after the first visit so far. Hence, only 18 milk samples of cows with clinical mastitis have been collected and analyzed. The outcomes used from the CBMRN project were cultured from 374 milk samples of cases of clinical mastitis from the 17 CON dairy farms in Alberta, resulting in 425 isolates. Mean IRCM within the group of CON farms was 0.189, within the group of ORG farms the mean IRCM was 0.300. On CON farms as well as on ORG farms, the IRCM was negatively correlated with the herd size with a correlation coefficient of -0.33 in CON farms and -0.82 in ORG farms (Figures 1A and 1B). TABLE 2. Herds and Incidence rates of clinical mastitis (number of cow cases per 365 cow-days at risk) in different managed farms (ORG vs. CON) CON ORG Herds 13 5 Cows/ herd, mean no. 96 98 Cases/ herd/ year, mean no. 16 22 IRCM Mean 0.189 0.300 Median 0.194 0.369 Minimum 0.049 0.100 Maximum 0.357 0.480 10

IRCM (cow cases per 365 cow-days at risk) 0.40 0.35 0.30 0.25 0.20 0.15 0.10 0.05 0.00 0 50 100 150 200 250 300 Herd size (mean number of milking cows) Figure 1A. Scatter plot of the incidence rate of clinical mastitis (IRCM) versus the herd size on CON farms. Correlation coefficient is -0.33. IRCM (cow-cases per 365 cow-days at risk) 0.6 0.5 0.4 0.3 0.2 0.1 0.0 0 50 100 150 200 250 Herd size (mean number of milking cows) Figure 1B. Scatter plot of the incidence rate of clinical mastitis (IRCM) versus the herd size on ORG farms. Correlation coefficient is -0.82 Aetiology In the diagram presented in Figure 2, the relative incidence of every mastitis pathogen in ORG and CON farming is shown. The predominant cause of clinical mastitis was for both farm types E. coli, which accounted for 20% of the cases of clinical mastitis in CON farms and for 16% in ORG farms. For the most pathogens the relative incidence in ORG and CON farms is quite similar, except for the relative incidence of Streptococcus spp. and S. dysgalactiae, which were higher in ORG farms. The proportion of culture-negative isolates is also larger in ORG farms. 11

No growth 12.24% 21.1% Mixed growth 11.76% 15.8% E. coli 15.8% 19.76% Klebsiella spp. 7.76% Enterobacter 0.71% Other Gram-negative 2.59% S. aureus Staph spp. 4.47% 5.3% 11.76% S. dysgalactiae 1.41% 5.3% S. uberis 4.47% 5.3% Strep spp. 9.88% 15.8% A. pyogenes 1.41% Corynebacterium spp. 3.53% 5.3% Other Gram-positive Yeasts 0.47% 7.76% 10.5% Organic Conventional 0% 5% 10% 15% 20% 25% Figure 2. Distribution of pathogens causing clinical mastitis on ORG farms and CON farms Treatments As would be expected in ORG and converting farms, antibiotics were used sporadically. One farm has not used antibiotics for more than 18 months, one farm just started milking and has not used antibiotics from the start, and the three other farms used antibiotics only in severe clinical disease. On the CON farms all cases of clinical mastitis were treated with antibiotics. Alternative treatments used on the ORG farms were stripping frequently by hand, udder massage with an ointment containing essential oils, homeopathic drugs and electro stimulation by attaching electrodes to two of the teats. All the farms used the udder ointments containing peppermint, two of the farms used electro stimulation. In most cases, several treatment strategies were combined, udder ointment was thereby often used in combination with one of the other treatments. DISCUSSION Results Because 4 farms quitted the project early, results of these farms were not taken into account in the analysis of the IRCM. They were included, however, for determining the relative incidence of mastitis pathogens. Incidence rate of clinical mastitis as showed in Table 1 was almost twice as high on ORG farms as on CON farms, but IRCM and mean number of cases per herd per year were calculated from just 18 samples collected in 2 months. To determine if IRCM in ORG farms is really higher than on CON farms, results of a longer sample period are needed. The fact that the calculated IRCM was higher at this time could be explained by environmental and seasonal factors. Samples were taken in the period where cows, coming from pasture, just had 12

been stalled inside and a study of Olde Riekerink et al. (2007) showed that IRCM is associated with season, the highest IRCM being found in the autumn and winter period. This could also be an explanation for the predominance of mastitis caused by E. coli as showed in Figure 1, because E. coli is associated with housing (Olde Riekerink et al., 2007). The higher proportion of Streptococcus spp. could be caused by the fact that al ORG farms use straw as bedding with which clinical mastitis caused by Streptococcus spp. is associated. The negative correlation between IRCM and herd size on CON farms is easily rejected when the two outlying results in the scatter plot, belonging to the two largest farms, are excluded. This also counts for the ORG farms. To support a negative correlation, more farms with a large herd should be taken into account. ORG farms did use less antimicrobial drugs than CON farms, but data of treatments used in every case of mastitis was not available at the time of writing this report. The much used ointment and electro-stimulation are thought to support the process of healing by causing vasodilatation and increasing blood flow, but there is no scientific evidence for that or their effectiveness against clinical mastitis. Significance of results Because the Organic Dairy Research Project has just started, very few results were available at the time of writing this report. Therefore, no significance could be calculated for any of the presented results. The nature of the Organic Dairy Research Project is to serve as a pilot study with low numbers of herds. To have enough power for statistical significance and to extrapolate results to the whole population, too few herds are currently participating. The larger national study, which will follow up this pilot study, will give more power to the results and will be able to conclude more about animal health in ORG farms. Results of CON farms and ORG farms were not obtained parallel in one research, but results of CON farms originated from another research study, the CBMRN. Therefore, correlations between ORG and CON farms are hard to support. Proportional distribution of etiologic pathogens and correlation between aetiology and farm type are also not provable because of a too low number of samples. Because the results of just a small selection of farms participating in the CBRMN are used, no significant correlation between herd size and IRCM could be calculated. Sample collection in CBMRN was not always reliable in some farms at the end of the sample collection period. Farmers had to take samples not only of clinical mastitis cases but also during lactation, when drying off cows and after calving. Motivation to take samples of every case therefore declined at the end of the project. Because management style differed between farms and management style has a great influence on aetiology and IRCM, no correlation with farm type (ORG vs. CON) could be made. CONCLUSIONS Neither IRCM, aetiology of clinical mastitis, nor the level of antibiotic drug resistance could yet be associated significantly with the method of production in this study. IRCM was found to be almost twice as high in ORG farms but short sample period (2 months) and time of sampling (begin of housing period) distort this image. Aetiology of clinical mastitis in ORG dairy had a tendency to a larger proportion of contagious pathogens, especially Streptococcus spp.. Antibiotic use was lower on ORG farms. Literature showed that currently, welfare is on average slightly higher in ORG dairy farming. Despite their benefits to environment and animal welfare, however, management standards and principles of ORG farming cannot guarantee better health, and lack in good regulation at some points, like parasite control. Because ORG farming regulations do not sufficiently cover every issue concerning animal health and do not sufficiently influence farmers management style, management style has still 13

more influence on health than production method. Therefore, better quality assurance and regulations would be needed to reach better health in ORG farms. Organic farming is relatively new and has potential because it is still growing, therefore health problems have to be studied more to optimize ORG dairying and its regulation. AKNOWLEDGEMENTS I would like to thank Herman Barkema and Ruurd Jorritsma for the opportunity to participate in several research projects at the University of Calgary Faculty of Veterinary Medicine and for their help with writing this report. I also like to thank Anke Wellen for her practical help during the field work and Amanda Reith for culturing all samples. REFERENCES 1. Agriculture and Agri-Food Canada, 2007. Sectoral Profile, www.agr.ca. 2. Barkema, H.W., Schukken, Y., Lam, T.J.G.M., Beiboer, M.L., Wilmink, H., Benedictus, G., 1998. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell count. Journal of Dairy Science 81, 411-419 3. Canadian General Standards Board, 2006. Organic production systems: General principles and management standards, 6 Livestock production. 4. Bennedsgaard, T.W., Thamsborg, S.M., Vaarst, M., Enevoldsen, C., 2003. Eleven years of organic dairy production in Denmark: herd health and production related to time of conversion and compared to conventional production, Livestock Production Science 80, 121-131 5. Bonny, S., 2006. Organic Farming in Europe: Situation and prospects, Institute National de la Reserche Agronomique, Notre Europe, 2006 6. Borell, E. von, Sorensen, J.T., 2004. Organic livestock production in Europe: aims, rules and trends with special emphasis on animal health and welfare, Livestock Production Science 90, 3-9 7. Busato, A., Trachsel, P., Schällibaum, M., Blum, J.W., 2000. Udder health and risk factors for subclinical mastitis in organic dairy farms in Switzerland, Preventive Veterinary Medicine 44, 205-220 8. Fall, N., Emanuelson, U., Martinsson, K., Jonsson, S., 2008. Udder Health at a Swedish research farm with both organic and conventional dairy cow management. Preventive Veterinary Medicine 83, 186-195 9. Hamilton, C., Emanuelson, U., Forslund, K., Hansson, I., Ekman, T., 2006. Mastitis and related management factors in certified organic dairy herds in Sweden. Acta Veterinaria Scandinavica 48:11 10. Hardeng F., Edge, V.L., 2001. Mastitis, ketosis and milk fever in 31 organic and 93 conventional Norwegian dairy herds. Journal of Dairy Science 84, 2673-2679 11. Hovi, M., Roderick, S., 1998. Mastitis therapy in organic dairy herds. Proceedings of the 1 st British Mastitis Conference 1998, 29-35 12. International Federation of Organic Agricultural Movement, Final Draft on the Definition of Organic Agriculture, 2007 13. International Federation of Organic Agricultural Movement, The Principles of Organic Agriculture, www.ifoam.org 14. Lam, T.J.G.M., 2008. Mastitis Control: From Science to practice. ISBN 978-90-8686-085-2 15. Macey, A., 2004. Certified Organic The status of the Canadian organic market in 2003, Report to Agriculture and Agri-Food Canada, Contract # 01B6830423 14

16. National Mastitis Council, 1999. Laboratory Handbook on Bovine Mastitis. National Mastitis Council, Madison WI 17. Nauta, W.J., Baars, T., Bovenhuis, H., 2006. Converting to organic dairy farming: consequences for production, somatic cell scores and calving interval of first parity Holstein cows. Livestock Production Science 99, 185-195 18. Olde Riekerink, R.G.M., Barkema, H.W., Stryhn, H., 2007. The effect of season on somatic cell count and the incidence of clinical mastitis. Journal of Dairy Science 90, 1704-1715 19. Poll, M., Ruegg, P.L., 2007. Relationship between antimicrobial drug usage and antimicrobial susceptibility of Gram-positive mastitis pathogens. Journal of Dairy Science 90, 262-273 20. Roesch, M., Perreten, V. Doherr, M.G., Schaeren, W., Schallibaum, M., Blum, J.W., 2006. Comparison of antibiotic resistance of udder pathogens in dairy cows kept on organic and conventional farms. Journal of Dairy Science 87, 989-997 21. Radostits, O.M., Gay, C.C., Hinchcliff, K.W., Constable, P.D., 2007. Veterinary Medicine, 10 th Edition, 673-727. ISBN 978-0702-07772 22. Sato, K., Bartlett, P.C., Erskine, R.J., Kaneene, J.B., 2005. A comparison of production and management between Wisconsin organic and conventional dairy herds. Livestock Production Science 93, 105-115 23. Sundrum, A., 2001. Organic livestock production: A critical review. Livestock Production Science 67, 207-215 24. United States Department of Agriculture, National Organic Program, 205.238, 2008 25. Vaarst, M., Enevoldsen, C., 1997 Patterns of clinical mastitis manifestation in Danish organic dairy herds. Journal of Dairy Research 64, 23-37 26. Vaarst, M., Bennedsgaard, T.W., Klaas, I. Nissen, T.B., Thamsborg, S.M., Østergaard, S., 2006. Development and daily management of an explicit strategy of nonusage of antimicrobial drugs in twelve Danish organic dairy herds. Journal of Dairy Science 89, 1842-1853 27. Vaarst, M., Thamsborg, S.M., Bennedsgaard, T.W., Houe, H., Enevoldsen, C., Aarestrup, F.M., de Snoo, A., 2003. Organic dairy farmers decision making in the first 2 years after conversion in relation to mastitis treatment. Livestock Production Science 80, 109-120 28. Valle, P.S., Lien, G., Flaten, O., Koesling, M., Ebbesvik, M., 2007. Herd health and health management in organic versus conventional dairy herds in Norway. Livestock Science 112, 123-132 29. Weller, R.F., Cooper, A., 1996. Health status of dairy herds converting from conventional to organic dairy farming. Veterinary Record 139, 141-142 30. Weller, R.F., Bowling, P.J., 2000. Health status of dairy herds in organic farming. Veterinary Record 146, 80-81 31. Willer, H., Yusefi, M., Sorensen, N., 2006. The World of Organic Agriculture 2006 - Statistics and Emerging Trends. 8th revised edition, International Federation of Organic Agriculture Movements (IFOAM), 186 pages, ISBN 3-934055 61-3 32. Willer, H., Yusefi, M., Sorensen, N., 2008. The World of Organic Agriculture 2008 Statistics and Emerging Trends, International Federation of Organic Agriculture Movements (IFOAM), ISBN IFOAM 978-3-934055-99-5 33. Zwald, A.G., Ruegg, P.L., Kaneene, J.B., Warnick, L.D., Wells, S.J., Fossler, C. Halbert, L.W., 2004, Management practices and reported antimicrobial usage on conventional and organic farms. Journal of Dairy Science 87, 191-201 15